AVROBIO regains Nasdaq minimum bid price compliance; matter closed

Tectonic Therapeutic, Inc.

Nasdaq notified AVROBIO on June 12, 2023 that bid price closed at or above $1.00 for 14 consecutive business days.
Prior deficiency notice on May 11, 2023 cited 30 consecutive business days below $1.00 from March 29 to May 10.
Regained compliance with Nasdaq Listing Rule 5450(a)(1) for continued listing on the Global Select Market.
Nasdaq has closed the matter regarding the minimum bid price requirement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.